Hemogenyx Pharmaceuticals Plc
HEMO.L
Price:
$1.2796
Market Cap:
$17.17M
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML), subset of acute lymphoblastic leukaemia, and myelodysplastic syndrome conditioning bone marrow transplants to substitute traditional chemotherapy and/or radiation; HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal H...[Read more]
Industry
Biotechnology
IPO Date
2015-11-09
Stock Exchange
LSE
Ticker
HEMO.L
PE Ratio
[-1.28]
ROE
[-0.18%]
Current Ratio
[4.38]
Dividend Yield
[0%]
Enterprise Value
[15.78M]
Dividend History
The ROE as of November 2024 (TTM) for Hemogenyx Pharmaceuticals Plc (HEMO.L) is -0.18%
According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current ROE is -0.18%. This represents a change of 300.73% compared to the average of -0.04% of the last 4 quarters.
Hemogenyx Pharmaceuticals Plc (HEMO.L) Historical ROE (quarterly & annually)
How has HEMO.L ROE performed in the past?
The mean historical ROE of Hemogenyx Pharmaceuticals Plc over the last ten years is -84.92%. The current -0.18% ROE has changed -99.79% with respect to the historical average. Over the past ten years (40 quarters), HEMO.L's ROE was at its highest in in the December 2019 quarter at 214.70%. The ROE was at its lowest in in the June 2019 quarter at -249.57%.
Average
-84.92%
Median
-121.76%
Minimum
-237.47%
Maximum
419.36%
Hemogenyx Pharmaceuticals Plc (HEMO.L) ROE by Quarter and Year
Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.52%
Maximum Annual ROE = 419.36%
Minimum Annual Increase = -372.23%
Minimum Annual ROE = -237.47%
| Year | ROE | Change |
|---|---|---|
| 2023 | -237.37% | 78.81% |
| 2022 | -132.75% | 44.56% |
| 2021 | -91.83% | -61.33% |
| 2020 | -237.47% | -156.63% |
| 2019 | 419.36% | -372.23% |
| 2018 | -154.04% | 39.06% |
| 2017 | -110.78% | 92.56% |
| 2016 | -57.53% | -75.25% |
| 2015 | -232.43% | 1.52% |
Hemogenyx Pharmaceuticals Plc (HEMO.L) Average ROE
How has HEMO.L ROE performed in the past?
The current ROE of Hemogenyx Pharmaceuticals Plc (HEMO.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-153.98%
5-year avg
-56.01%
10-year avg
-84.92%
Hemogenyx Pharmaceuticals Plc (HEMO.L) ROE vs. Peers
How is HEMO.L’s ROE compared to its peers?
Hemogenyx Pharmaceuticals Plc’s ROE is greater than Omega Diagnostics Group PLC (-35.47%), greater than genedrive plc (-281.82%), greater than Avacta Group Plc (-74.00%), greater than Novacyt S.A. (-42.30%), greater than Synairgen plc (-29.40%),
| Company | ROE | Market cap |
|---|---|---|
| -35.47% | $4.94M | |
| -281.82% | $12.66M | |
| -74.00% | $187.54M | |
| -42.30% | $39.27M | |
| -29.40% | $9.06M |
Build a custom stock screener for Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Hemogenyx Pharmaceuticals Plc (HEMO.L) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Hemogenyx Pharmaceuticals Plc's ROE?
How is the ROE calculated for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the highest ROE for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 3-year average ROE for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
What is the 5-year average ROE for Hemogenyx Pharmaceuticals Plc (HEMO.L)?
How does the current ROE for Hemogenyx Pharmaceuticals Plc (HEMO.L) compare to its historical average?